Share-based Payment Arrangement, Expense of Nuvation Bio Inc. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Nuvation Bio Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • Nuvation Bio Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $8,021,000, a 7.3% increase year-over-year.
  • Nuvation Bio Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $38,095,000, a 48% increase year-over-year.
  • Nuvation Bio Inc. annual Share-based Payment Arrangement, Expense for 2024 was $32,275,000, a 65% increase from 2023.
  • Nuvation Bio Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19,513,000, a 20% increase from 2022.
  • Nuvation Bio Inc. annual Share-based Payment Arrangement, Expense for 2022 was $16,292,000, a 76% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Nuvation Bio Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $38,095,000 $8,021,000 +$545,000 +7.3% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $37,550,000 $12,031,000 +$2,462,000 +26% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $35,088,000 $7,854,000 +$2,813,000 +56% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q4 2024 $32,275,000 $10,189,000 +$6,467,000 +174% 01 Oct 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q3 2024 $25,808,000 $7,476,000 +$2,045,000 +38% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025 2025 Q3
Q2 2024 $23,763,000 $9,569,000 +$4,046,000 +73% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $19,717,000 $5,041,000 +$204,000 +4.2% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q4 2023 $19,513,000 $3,722,000 -$1,266,000 -25% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $20,779,000 $5,431,000 +$2,491,000 +85% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024 2024 Q3
Q2 2023 $18,288,000 $5,523,000 +$736,000 +15% 01 Apr 2023 30 Jun 2023 10-Q 05 Aug 2024 2024 Q2
Q1 2023 $17,552,000 $4,837,000 +$1,260,000 +35% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $16,292,000 $4,988,000 +$2,188,000 +78% 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $14,104,000 $2,940,000 +$191,000 +6.9% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $13,913,000 $4,787,000 +$2,634,000 +122% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $11,279,000 $3,577,000 +$2,011,000 +128% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q4 2021 $9,268,000 $2,800,000 +$1,675,000 +149% 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $7,593,000 $2,749,000 +$2,401,000 +690% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $5,192,000 $2,153,000 +$1,764,000 +453% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $3,428,000 $1,566,000 +$1,226,000 +361% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $2,202,000 $1,125,000 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
Q3 2020 $348,000 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $389,000 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $340,000 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1

Nuvation Bio Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $32,275,000 +$12,762,000 +65% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
2023 $19,513,000 +$3,221,000 +20% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $16,292,000 +$7,024,000 +76% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024 2023 FY
2021 $9,268,000 +$7,066,000 +321% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2020 $2,202,000 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.